Back to CITIGROUP INC CITIGROUP INC

NVAXNVAX

Showing 8 of 11 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in NOVAVAX INC

Yes. Citigroup holds 513,201 shares of NVAX (Novavax), worth $4.8M, as of its Q2 2026 13F filing. It increased the position from 40,854 shares in Q1 2026. Citigroup has held NVAX in every 13F on record since Q4 2023, 11 quarterly filings.

Current Value

$4.8M

Current Shares

513,201

Total Value Change

-$9.5M

Total Shares Change

-622,021

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
513,201
+1156.2%
$4.8M0.0%$9.42
43
2026-Q1
Decreased
40,854
-41.6%
$332,5520.0%$8.14
0
2025-Q4
Increased
69,925
+164.7%
$469,8960.0%$6.72
39
2025-Q3
Decreased
26,414
-78.4%
$229,0100.0%$8.67
0
2025-Q2
Decreased
122,464
-64.7%
$771,5230.0%$6.30
0
2025-Q1
Decreased
347,330
-66.7%
$2.2M0.0%$6.41
0
2024-Q4
Decreased
1M
-8.2%
$8.4M0.0%$8.04
0
2024-Q3
Increased
1.1M
+32.0%
$14.3M0.0%$12.63
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used